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Abstract
Background: Crystalloids are first line in fluid resuscitation therapy, however there is a lack of evidence-based
recommendations on the volume to be administered. Therefore, we aimed at comparing the systemic
hemodynamic and respiratory effects of volume replacement therapy with a 1:1 ratio to the historical 1:3 ratio.
Methods: Anesthetized, ventilated rats randomly included in 3 groups: blood withdrawal and replacement with
crystalloid in 1:1 ratio (Group 1, n = 11), traditional 1:3 ratio (Group 3, n = 12) and a control group with no
interventions (Group C, n = 9). Arterial blood of 5% of the total blood volume was withdrawn 7 times, and replaced
stepwise with different volume rations of Ringer’s acetate, according to group assignments. Airway resistance (Raw),
respiratory tissue damping (G) and tissue elastance (H), mean arterial pressure (MAP) and heart rate (HR) were
assessed following each step of fluid replacement with a crystalloid (CR1-CR6). Lung edema index was measured
from histological samples.
Results: Raw decreased in Groups 1 and 3 following CR3 (p < 0.02) without differences between the groups. H
elevated in all groups (p < 0.02), with significantly higher changes in Group 3 compared to Groups C and 1
(both p = 0.03). No differences in MAP or HR were present between Groups 1 and 3. Lung edema was noted
in Group 3 (p < 0.05).
Conclusions: Fluid resuscitation therapy by administering a 1:1 blood replacement ratio revealed adequate
compensation capacity and physiological homeostasis similar with no lung stiffening and pulmonary edema.
Therefore, considering this ratio promotes the restrictive fluid administration in the presence of continuous
and occult bleeding.
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Background
With the increased awareness of the potential harmful
effect of colloids on the organs, crystalloids are consid-
ered as first line fluid resuscitation therapy. Moreover,
goal-directed fluid therapy is now a well-established
strategy in routine clinical practice in the perioperative
period. The main feature of this strategy is to reduce the
amount of fluid administered to the patients while
maintaining optimal cardiac output and adequate organ
perfusion [1, 2]. However, crystalloids have short
hemodynamic beneficial effect due to the extravasation
into the interstitial space [3] with a very low (less than
20%) intravascular volume effect [4].
There are various clinical situations where continuous
and occult bleeding (such as liver surgery and trauma,
transplants, scoliosis surgery, etc.) may occur and the
clinicians may have to face higher ratio of fluid replace-
ment to maintain hemodynamic stability. Despite the
routine use of crystalloids in these clinical situations, the
optimal volume to be administered to re-establish blood
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volume and maintain optimal cardiac output and
end-organ perfusion is arbitrary. This ambiguity arises
from the lack of evidence-based recommendations with
regard to the volume of crystalloid solution to be admin-
istered in order to compensate for the same blood lost
volume. Historically, 3- to 4-fold ratio is recommended
in various textbooks as a traditional approach to coun-
terweigh blood loss [5]. Despite the recent European
guidelines to use a restricted volume replacement [6],
closer to a 1:1 ratio, there have been no studies provid-
ing evidence for the choice of the optimal crystalloid
volume to be administered to maintain hemodynamic
stability with minimal adverse effect due to interstitial
water extravasation.
We recently demonstrated that measurements of
respiratory mechanics provide sensitive indices of lung
water extravasation as a consequence of fluid replace-
ment therapy in an experimental model of acute
hemorrhage [7, 8]. Therefore, we aimed at using a simi-
lar approach to clarify the debate on the optimal crystal-
loid volume ratio following occult and continuous
bleeding. We hypothesized that when compared to the
historical ratio of 1:3, crystalloid fluid replacement in a
1:1 ratio is sufficient to ensure hemodynamic stability




The experimental procedures were approved by the
institutional ethics committee for experimental research
of the University of Szeged (no. I-74-50/2012) and by
the National Food Chain Safety and Animal Health
Directorate of Csongrád County, Hungary (no. XIV/152/
2013). The procedures were performed according to the
guidelines of the Scientific Committee of Animal
Experimentation of the Hungarian Academy of Sciences
(updated Law and Regulations on Animal Protection:
40/2013. (II. 14.) Government of Hungary), following the
EU Directive 2010/63/EU on the protection of animals
used for scientific purposes, and reported in compliance
with the ARRIVE guidelines.
Animal preparations
Anesthesia of 32 male adult Wistar rats (330 [285–388]
g from the animal facility of Faculty of Pharmacy,
University of Szeged, Hungary) was induced with an in-
traperitoneal injection of sodium pentobarbital (45mg/kg).
Tracheostomy was performed after subcutaneous adminis-
tration of lidocaine (2–4mg/kg) and a polyethylene can-
nula was introduced into the trachea (16 G, B. Braun
Melsungen AG, Melsungen, Germany). A small animal
ventilator (Model 683, Harvard Apparatus, South Natick,
MA, USA) was used to ventilate the animals in a supine
position with room air (70 breaths/min, tidal volume
7 ml/kg) through the tracheal tube. The left femoral
vein was cannulated (Abbocath 22 G) for drug deliv-
ery and fluid replacement. This line was used to
maintain anesthesia by repeated injections of sodium
pentobarbital (12 mg/kg, every 30 min) and muscle
relaxation was achieved by regular administration of
pipecuronium (0.1 mg/kg, every 30 min, Arduan,
Richter-Gedeon, Budapest, Hungary). The left femoral
artery was catheterized (Abbocath 22 G) and con-
nected to a pressure transducer (Model TSD104A,
Biopac, Santa Barbara, CA, USA) for continuous
systemic blood pressure monitoring to assess mean
arterial pressure (MAP), and to allow blood with-
drawal, as part of the experimental protocol. A data
collection and acquisition system (Biopac, Santa
Barbara, CA, USA) was used to monitor the MAP,
ECG and heart rate (HR) continuously. Body
temperature was kept in the 37 ± 0.5 °C range by
utilizing a heating pad.
Measurement of respiratory mechanical parameters
The forced oscillation technique was applied in short
(6-s-long) end-expiratory pauses, as detailed previ-
ously [9, 10] to obtain the input impedance of the
respiratory system (Zrs). Briefly, ventilation was
ceased at end-expiration and the tracheal cannula was
switched to a loudspeaker-in-box system by means of
a three-way tap. A computer-generated small ampli-
tude (< ±1 cmH2O) pseudorandom signal composed
of 23 non-integer multiples ranging 0.5–20.75 Hz was
delivered by the loudspeaker through a 100-cm-long,
2-mm-internal diameter polyethylene wave-tube. The
lateral pressures were measured at the loudspeaker
end (P1) and at the tracheal end (P2) of the
wave-tube by using two identical pressure transducers
(model 33NA002D, ICSensors, Milpitas, CA, USA).
The signals P1 and P2 were low-pass filtered at 25Hz, and
digitized by a data acquisition board (NI USB-6211,
National Instruments, Austin, TX) at a rate of 256 Hz.
Pressure transfer functions (P1/P2) were calculated with
fast Fourier transformation (4-s time windows and 95%
overlapping) from each 6-s recordings. Zrs was calculated
as the load impedance of the wave-tube [11]. The input
impedance of the ET tube and the connections was also
determined, and was subtracted from each Zrs spectrum.
A model containing a frequency-independent resist-
ance (Raw) and inertance (Iaw) and a constant-phase
tissue compartment consisting of tissue damping (G)
and elastance (H) was fitted to the Zrs spectra by
minimizing the weighted difference between the mea-
sured and the modelled impedance data [12]. G de-
scribes the dissipative (damping or resistive) properties,
while H reflects stiffness (elastance) of the respiratory
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tissues. Raw and Iaw characterize mainly the resistance
and inertance of the airways, since the contribution of
the chest wall to these parameters in rats is minor [13].
Pulmonary edema assessments
At the end of the experimental protocol the animals
were euthanized with an intravenous overdose of pento-
barbital sodium (300 mg/kg), then a midline thoracot-
omy was performed. The right lungs were fixed by
instilling 4% formaldehyde at a hydrostatic pressure of
20 cmH2O via the tracheal cannula. The lungs were ex-
cised in one piece and placed into 4% buffered formalin
until further processing. After complete fixation, transhi-
lar horizontal sections (perpendicular to the longitudinal
axes of the lung from the hilum) were embedded in par-
affin. Two 5-μm sections were prepared in each lung
specimen and were stained with hematoxylin-eosin.
Digitized images of 10 non-overlapping fields of view
were used to obtain the edema index around randomly
selected pulmonary vessels by dividing the lumen area
by the total area of the pulmonary vessel (edema cuff
area + vessel lumen area). Histological images were
analyzed by the same investigator in a blind fashion and
in a random sequence by using JMicroVision image
analysis software (version 1.2.7).
Three-to-four tissue samples were dissected from the
different lobes of the non-fixated left lungs; these
samples were weighed to establish the wet-to-dry weight
ratio (W/D) as an index of the lung water content.
Study protocol
The rats were assigned to the protocol groups randomly
and the same experimental protocol was applied to both
treatment groups apart from the volume of replaced
fluid (as depicted in Fig. 1). Following animal prepara-
tions and reaching a steady-state condition, a lung
hyperinflation was applied by occluding the expiratory
port of the ventilator for 1 respiratory cycle to
standardize the lung volume history. Baseline respiratory
mechanical parameters were determined by measuring 4
reproducible Zrs data sets. Blood loss was achieved by
withdrawing 5% (approximately 1 ml) of total estimated
blood volume (TBV) [14] via the femoral artery, then
after 7 min, withdrawal of blood was repeated once again
identically. Following these two withdrawals of arterial
blood, fluid replacement was carried out by a rapid
injection of Ringer’s acetate solution (Ringerfundin B.
Braun, B. Braun Melsungen AG, Melsungen, Germany)
into the femoral vein in accordance with the group allo-
cation: Group 1 (n = 11) received 5% of TBV (1:1 ratio)
and Group 3 (n = 12) received 15% of TBV (1:3 ratio) at
each replacement. A set of Zrs data was recorded three
minutes later. The blood withdrawal-replacement was
repeated five more times (until a total of 7 withdrawal
and 6 replacement steps) with additional Zrs recordings
after each replacement maneuvers. Blood gas analyses
were performed from the first, fourth and sixth
withdrawn arterial blood samples (epoc Reader and
Host, Epocal Inc., Ottawa, ON, Canada) to determine
hematocrit (Hct), pH and partial pressures of oxygen
(PaO2) and carbon dioxide (PaCO2). Arterial oxygen
content (CaO2) of the blood was calculated based on the
following equation: CaO2 = SaO2 x Hb × 1.39 + (PaO2 ×
0.03) with hemoglobin estimated from the hematocrit
level based on the formula Hb (g/dl) = Hct (%)/3 [15]. At
the end of the experimental protocol the lungs were
processed for assessment of pulmonary edema as
detailed above. Each withdrawal-replacement step lasted
about 12–15min, resulting in a total duration of the
fluid resuscitation period of around 90min.
A control group (Group C, n = 9) was also used with
identical timing of the measurements, but no withdrawal
and replacement, apart from approximately 0.3 ml for
each arterial blood gas sample at the same time as in the
protocol groups.
Statistical analyses
Group mean averages with SE values are reported.
Normality was checked with the Shapiro-Wilk test.
Considering the mean values of the primary outcome, H
(4800 cmH2O/l) and its variability (650 cmH2O/l) estab-
lished in earlier studies in rats [7], sample size estima-
tion revealed that 10 rats are necessary in each group to
detect 20% difference in the three groups with 80%
Fig. 1 Experimental protocol. BL: baseline, W1-W7: blood withdrawal (5% of total blood volume), CR1-CR6: fluid replacement maneuvers, Zrs: a
set of respiratory impedance measurements, BG: arterial blood gas measurements. Each withdrawal-replacement step lasted about 12–15 min,
resulting in a total duration of the fluid resuscitation period of around 90 min
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power at significance level of 0.05. Two-way repeated
measures analysis of variance (ANOVA) was used with
the variables group assessment and time to establish the
effects of these factors on respiratory mechanical, blood
gas and hemodynamic parameters. The Holm-Sidak
multiple comparison procedure was employed to
compare the mechanical, blood gas and hemodynamic
parameters under different conditions versus controls of
both group assessment (Group C) and time (BL or first
blood gas measurement). One-way ANOVA with the
factor group assessment was used to assess effects of
fluid volume on edema indices and to assess differences
of final responses (those obtained at CR6). The
Holm-Sidak multiple comparison procedure was applied
for post hoc tests. The statistical tests were performed
with SigmaPlot statistical software package (Version 13,
Systat Software, Inc. Chicago, IL, USA). In each test, a
significance level of p < 0.05 was applied.
Results
Body weights of the rats did not differ significantly
between the groups (335 [285–386] g for Group C,
333 [285–388] g for Group 1 and 324 [285–380] g
for Group 3).
Changes in respiratory mechanical parameters follow-
ing each fluid replacement maneuver are demonstrated
in Fig. 2. No significant changes in Raw were observed
in Group C. While significant decreases in Raw were
observed in Groups 1 (CR2–CR6, each p < 0.02) and 3
(CR3–CR6, each p < 0.02), there was no evidence for a
difference in the relative changes in Raw between the
groups. No significant changes were observed in G in
any of the groups apart from slight increases from CR4
in Group 1 (CR4–CR6, each p < 0.03). Respiratory elas-
tance worsened in all groups with mild changes in
groups C and 1 (CR2–CR6, each p < 0.01 and CR1–CR6,
each p < 0.01 for group C and group 1, respectively),
whereas a significantly more severe deterioration was
observed with time in group 3 (CR1–CR6, each p < 0.03).
Parameters assessed from arterial blood gas analyses
are demonstrated in Table 1. The study protocol led to a
significant decrease in Hct in both Groups 1 (p < 0.001
at W4 and W6) and 3 (p < 0.001 at W4 and W6). How-
ever, in comparison to Group C and 1, fluid replacement
with a 1:3 ratio resulted in significantly lower values
of Hct from the fourth blood withdrawal maneuver
(W4, p < 0.001), implying lowered Hct in Group 3
after the third fluid replacement maneuver (CR3).
Slight decrements of pH were obtained in Group 1
(p = 0.019 and p < 0.001 at W4 and W6, respectively)
and Group 3 (p = 0.049 and p < 0.001 at W4 and W6,
respectively) during the fluid replacement protocol,
however no significant differences were detected
between the groups. No significant changes were
detected in PaO2 and PaCO2 in any of the protocol
groups. Significant decreases were observed in CaO2
both in Group 1 and Group 3 at fourth (W4) and
sixth (W6) blood withdrawal maneuvers (p < 0.001 for
all) with significantly lower values in Group 3
compared to Group C at W6 (p = 0.004).
Figure 3 exhibits the changes of systemic
hemodynamic parameters. No significant changes in
MAP or HR were detected in Group C, however, signifi-
cantly lower values of MAP were observed in Group 1
and Group 3 from the fifth blood withdrawal (W5–CR6,
each p < 0.05). The relative decreases in MAP at the end
of the protocol were significantly greater in both Group
1 and Group 3 than those observed in Group C (p = 0.03
for both). No significant changes of HR were detected
during the protocol.
The results of lung edema assessments obtained from
the protocol groups are summarized in Fig. 4.
Wet-to-dry lung weight ratio was significantly greater in
Group 3 than those obtained in Groups C (p = 0.05) and
1 (p = 0.048). Histological lung edema index was
significantly elevated in Group 1 compared to Group C
(p < 0.001), with even more severe elevations observed in
Group 3 compared to Group 1 (p = 0.05).
Discussion
We demonstrated in the present experimental study that
compensating blood loss with crystalloids in a ratio of
1:1 led to lack of adverse alterations in the lung with
maintenance of physiological homeostasis. Conversely,
the use of a historical ratio of 1:3 resulted in a deterior-
ation in respiratory tissue stiffness as a consequence of
perivascular edema development. Moreover, fluid re-
placement in a ratio of 1:3 induced greater hemodilution
as expressed in the significant decrease in the oxygen
content of the blood.
In agreements with our previous study when the blood
loss was replaced with normal saline [7], a slight
decrease was observed in Raw in Group 1 and Group 3
following fluid resuscitations. While this bronchodilation
is presumably caused by a catecholamine-release in-
duced by a loss of blood volume [8], the lack of
differences at the final replacement maneuver suggests
that this catecholamine-release is counteracted by the
restoration of vascular filling with crystalloid, which
propagates the recovery of bronchial geometry.
The gradual increases in the respiratory tissue stiff-
ness manifested by the elevations of H in Group C
can be most probably attributed to a slight formation
of atelectatic areas in the dependent lung regions sub-
sequent to general anesthesia and supine position
leading to lung volume loss [16]. Interestingly, fluid
replacement with crystalloid at 1:1 ratio resulted in a
similar trend in H, indicating that such intervention
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has no deleterious consequences in the lung tissue
mechanics. In contrast with these mild changes, fluid
replacement therapy with the larger crystalloid vol-
ume (1:3) led to severe respiratory tissue stiffening
when the circulatory blood volume was increased
above 140% of baseline. These adverse respiratory
mechanical changes can be attributed to a significant
increase in the pulmonary edema extent subsequent
to severe hemodilution manifested in the significant
drop in Hct level. The excessive edema development
in the animals of Group 3 may lead ultimately to de-
terioration in gas exchange [17–19], and may be a
risk factor for the development of acute respiratory
distress syndrome [20]. Hypoxemia was not observed
in the present study due to the relatively limited drop
in CaO2 and Hct that allowed the maintenance of
Fig. 2 Mean (±SE) values of respiratory mechanical parameters during the experimental protocol. ΔBV: changes of total blood volume. The
absolute values of airway resistance (Raw), tissue damping (G) and tissue elastance (H) over the experimental protocol (left) and their changes
following the last fluid replacement maneuver relative to their corresponding baseline (right). BL: baseline. CR1-CR6: replacement maneuvers.
*: p < 0.05 in Group 1 vs BL, #: p < 0.05 in Group 3 vs BL, †: p < 0.05 in Group C vs BL. §: p < 0.05 in the relative changes
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physiological homeostasis and the short duration of
the experiment (90 min).
The mechanisms responsible for the changes in the
respiratory mechanics following hemodilution are still to
be fully characterized. In an earlier in vitro model, we
demonstrated that decreased hematocrit values resulted in
no change of Raw and decreases of G and H [21]. The
contradiction between the previous in vitro and the
current in vivo results suggest that although hematocrit
content and blood viscosity affect the mechanical proper-
ties of the respiratory system, our present findings are
governed mainly by systemic factors, such as the systemic
catecholamine-release subsequent to blood loss [8].
There is still no clear consensus on the optimal fluid
replacement therapy. Colloids have been used as
volume-sparing agents for large-scale fluid losses [22],
however due to the recent controversies related to
hydroxyethyl-starch [23, 24] and albumin [24, 25], crys-
talloids are still highly recommended for fluid resuscita-
tion [6, 26]. In clinical practice, not only the type of the
applied solution, but the applied volume is also under
debate. It is commonly accepted that although crystal-
loids are recommended in a goal-directed manner [27],
these solutions are still applied in higher volumes com-
pared to colloids [28]. There is increasing evidence for
the benefit of intravenous fluid restriction during the
perioperative period on patient recovery and outcome
[29, 30]. Our findings support the clinical concept of
reducing the administered crystalloids volume to a ratio
of 1:1 to avoid any additional detrimental effects on the
lungs, which may further contribute to the major post-
operative complications [3, 31, 32].
While no significant differences in the systemic
hemodynamic parameters were observed between Group
1 and Group 3, the magnitude of the significant decrease
in MAP was similar in both Groups 1 and 3. This result
suggests an equality of 1:1 and 1:3 ratios in terms of
systemic hemodynamic effects. In addition, our findings
are in line with the goal-oriented therapy concept,
which promotes fluid restriction associated with early
onset of vasopressors to maintain perfusion pressure
[32, 33]. Therefore, comparing the traditional 1:3–1:4
ratios for crystalloids implied by textbooks [5] with a
smaller, 1:1 ratio is already able to ensure physiological
homeostasis without compromising the respiratory
function.
The choice of the replacement crystalloid was based
on the current recommendations of favoring balanced
crystalloids over normal saline (0.9% NaCl) [26, 27, 34].
The use of balanced solutions results in lower occur-
rences of hypochloremia and metabolic acidosis [35].
This may be reflected in the maintenance of normal
physiological pH in the animals of Group 1 in the
present study, as opposed to development of acidosis in
a similar earlier protocol by using normal saline [7].
As concerns the changes of Raw and H following fluid
resuscitation, the present findings demonstrate similar
trends to those observed previously [7]. However, the
results of the present study differs from the previous
findings for H, with an increase of approximately 15%
detected in our present study opposed to as high as ~
40% when fluid replacement was performed with 1:1
crystalloid [7]. These differences were also consistent
with the development of more severe of lung edema.
Table 1 Mean ± SE values of parameters obtained from arterial blood gas measurements
W1 W4 W6
Hematocrit (%) Group C 35.60 ± 0.77 34.24 ± 1.29 33.04 ± 1.88
Group 1 36.64 ± 0.72 32.26 ± 0.81* 29.63 ± 1.23*$
Group 3 36.39 ± 0.77 30.30 ± 1.09*$ 27.09 ± 0.60*$§
pH Group C 7.50 ± 0.01 7.45 ± 0.01 7.45 ± 0.03
Group 1 7.52 ± 0.02 7.45 ± 0.03* 7.41 ± 0.02*
Group 3 7.54 ± 0.02 7.47 ± 0.02* 7.41 ± 0.03*
PaO2 (mmHg) Group C 70.75 ± 2.10 63.21 ± 2.86 67.35 ± 1.73
Group 1 74.24 ± 2.84 69.06 ± 3.55 75.43 ± 3.22
Group 3 75.28 ± 2.55 67.00 ± 4.10 71.06 ± 1.15
PaCO2 (mmHg) Group C 30.51 ± 1.74 30.63 ± 1.57 27.57 ± 3.08
Group 1 30.08 ± 1.55 31.07 ± 1.34 31.21 ± 1.49
Group 3 27.94 ± 0.97 29.71 ± 0.97 23.52 ± 2.34
CaO2 (ml O2/100 ml) Group C 15.67 ± 0.38 14.36 ± 0.56 14.37 ± 0.94
Group 1 16.29 ± 0.35 14.00 ± 0.36* 12.97 ± 0.48*
Group 3 16.21 ± 0.43 12.91 ± 0.48* 11.78 ± 0.22*$
PaO2 and PaCO2: arterial partial pressures of O2 and CO2, respectively. CaO2: arterial oxygen content. W blood withdrawal.*: p<0.05 vs. W1, $: p<0.05 vs. Group C,
§: p<0.05 vs. Group 1.
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The primary reason for these differences can also be at-
tributed to the use of different crystalloid solutions in
the two studies: normal saline in the previous one and a
balanced solution (Ringer’s acetate) in the current study.
It has been previously reported that higher levels of
body surface indexed extravascular lung water (EVLWI)
can be detected in a swine model of fluid resuscitation
of hemorrhagic shock when normal saline is used as op-
posed to a balanced crystalloid solution (Ringer’s lactate)
[36]. Our results also support that balanced crystalloids
Fig. 4 Edema index obtained by ratio of perivascular edema cuff and vascular area from the histological samples. *: p < 0.05
Fig. 3 Mean (±SE) values of hemodynamic parameters during the experimental protocol (both at replacement and withdrawal steps). ΔBV:
changes of total blood volume. Absolute values of mean arterial pressure (MAP) and heart rate (HR) over the experimental protocol (left) and
their changes following the last replacement compared to baseline (right). BL: baseline. CR1-CR6: replacement maneuvers, W1-W7: blood
withdrawal steps. *: p < 0.05 in Group 1 vs BL, #: p < 0.05 in Group 3 vs BL. §: p < 0.05 in the relative changes
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are more favorable opposed to normal saline in terms of
pulmonary edema formation [27, 34].
A limitation of our results is related to the experimen-
tal setting. The total respiratory system impedance data
comprises contributions from the pulmonary system and
the surrounding tissues (e.g. diaphragm and the chest
wall) [13]. This means that the mechanical parameters
obtained in the present study may not solely reflect
changes in the pulmonary system, particularly for the
tissue parameters [13]. We are not aware of any previous
studies addressing the mechanical changes of the chest
wall following hemodilution, however, no changes were
reported in the resistance and elastance of the chest wall
following severe oleic acid-induced interstitial edema
[37]. Therefore, we believe that the mechanical proper-
ties of the chest wall would not change substantially
following hemodilution and the changes we detected are
mainly of pulmonary origin. However, due to the mask-
ing effects of the fairly constant extrapulmonary tissue
mechanical compartments, the real pulmonary mechan-
ical changes are expected to be of greater magnitude.
Another limitation of our experimental design is related
to the lack of injured tissues like in the presence of trau-
matism, where hemodilution with crystalloids may affect
coagulation factors with subsequent rebleeding. How-
ever, our primary aim was to investigate intravascular
volume expansion mimicking a clinical situation where
the coagulation pathway is functional. While our model
did not aim at maintaining the colloid-osmotic pressures
or the level of coagulation factors, it still represents
clinical approaches resulting from continuous occult
bleeding and/or application of stable coagulation fac-
tors with crystalloids avoiding fresh frozen plasma.
Accordingly, our findings do not allow any conclu-
sions regarding volume replacement under trauma
conditions. A further limiting factor is related to the
lack of direct monitoring of cardiac output as an in-
dicator of optimal organ perfusion. However, the
homeostasis remained physiological (Table 1) despite
the drop in MAP, which indicated that anaerobic me-
tabolism did not occur.
Conclusions
In summary, the results of the present study provide
evidence for the optimal fluid replacement ratio when
considering crystalloids for fluid replacement follow-
ing blood loss. Accordingly, a ratio of 1:1 is more ap-
propriate than the historical approach since it is able
to meet the needs for maintaining homeostasis while
avoiding the adverse effects related to fluid extravasa-
tion. With the limitations of extrapolating experimental
results to clinical practice, our findings may suggest that
considering crystalloid fluid replacement in a ratio of 1:1
to compensate continuous occult bleeding maintains
appropriate organ perfusion without the adverse conse-
quences of fluid extravasation.
Abbreviations
ANOVA: Analysis of variances; BL: Baseline; CaO2: Arterial oxygen content;
CR1–6: Crystalloid replacement steps; EVLWI: Extravascular lung water;
G: Tissue damping; H: Tissue elastance; Hb: Hemoglobin; Hct: Hematocrit;
HR: Heart rate; Iaw: Airway inertance; MAP: Mean arterial pressure;
P1: Pressure at the loudspeaker end; P2: Pressure at the tracheal end;
PaCO2: Arterial partial pressures of carbon dioxide; PaO2: Arterial partial
pressures of oxygen; pH: Arterial pH; Raw: Airway resistance; TBV: Total blood
volume; W/D: Wet-to-dry weight ratio; W1–7: Blood withdrawal steps;
Zrs: Impedance of the respiratory system
Acknowledgements
The authors wish to thank Orsolya Ivánkovitsné Kiss for her technical
assistance during the experiments.
Funding
This study was funded by a Hungarian Basic Research Council Grant
(OTKA-NKFIH K115253) and the Economic Development and Innovation
Operational Programme in Hungary co-financed by the European Union
and the European Regional Development Fund (Grant GINOP-2.3.2-15-
2016-00006). Gergely H. Fodor was supported by the NTP-EFÖ-P-15
project by the Human Capacities Grant Management Office and the
Hungarian Ministry of Human Capacities (NTP-EFÖ-P-15-0543).
Availability of data and materials
The datasets used and/or analyzed during the current study are available
from the corresponding author on reasonable request.
Authors’ contributions
GHF: study design, data collection, data analyses and article drafting. WH:
study design, interpretation of the results and article drafting. ALB: data
collection and data analyses. RS: data collection and data analyses. BB: study
design, interpretation of the results and article drafting. FP: study design,
data analyses, interpretation of the results and article drafting. All authors
have read, critically revised and accepted the final manuscript.
Ethics approval and consent to participate
The experimental procedures were approved by the institutional ethics
committee for experimental research of the University of Szeged (no. I-74-
50/2012) and by the National Food Chain Safety and Animal Health
Directorate of Csongrád County, Hungary (no. XIV/152/2013). The procedures
were performed according to the guidelines of the Scientific Committee of
Animal Experimentation of the Hungarian Academy of Sciences (updated
Law and Regulations on Animal Protection: 40/2013. (II. 14.) Government of
Hungary), following the EU Directive 2010/63/EU on the protection of





The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Author details
1Department of Medical Physics and Informatics, University of Szeged, 9
Koranyi fasor, Szeged H-6720, Hungary. 2Unit for Anesthesiological
Investigations, Department of Anesthesiology, Pharmacology and Intensive
Care, University Hospitals of Geneva, University of Geneva, 1 Rue Michel
Servet, CH-1205 Geneva, Switzerland. 3Department of Anesthesiology and
Intensive Therapy, University of Szeged, 8 Semmelweis str, Szeged H-6725,
Hungary.
Fodor et al. BMC Anesthesiology           (2019) 19:21 Page 8 of 9
Received: 14 June 2018 Accepted: 4 February 2019
References
1. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E,
Tomlanovich M. Early goal-directed therapy collaborative G: early goal-
directed therapy in the treatment of severe sepsis and septic shock.
N Engl J Med. 2001;345(19):1368–77.
2. Goepfert MS, Richter HP, Zu Eulenburg C, Gruetzmacher J, Rafflenbeul E,
Roeher K, von Sandersleben A, Diedrichs S, Reichenspurner H, Goetz AE, et
al. Individually optimized hemodynamic therapy reduces complications and
length of stay in the intensive care unit: a prospective, randomized
controlled trial. Anesthesiology. 2013;119(4):824–36.
3. Hahn RG, Lyons G. The half-life of infusion fluids: an educational review.
Eur J Anaesthesiol. 2016;33(7):475–82.
4. Jacob M, Chappell D, Hofmann-Kiefer K, Helfen T, Schuelke A, Jacob B,
Burges A, Conzen P, Rehm M. The intravascular volume effect of Ringer's
lactate is below 20%: a prospective study in humans. Crit Care.
2012;16(3):R86.
5. Puyana JC. Resuscitation of hypovolemic shock. In: Fink MP, editor.
Textbook of critical care. 5th ed. Philadelphia: Elsevier Saunders;
2005. p. 1939–40.
6. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar
E, Filipescu D, Hunt BJ, Komadina R, Nardi G, et al. The European guideline
on management of major bleeding and coagulopathy following trauma:
fourth edition. Crit Care. 2016;20:100.
7. Fodor GH, Babik B, Czovek D, Doras C, Balogh AL, Bayat S, Habre W, Petak F.
Fluid replacement and respiratory function: comparison of whole blood
with colloid and crystalloid: a randomised animal study. Eur J Anaesthesiol.
2016;33(1):34–41.
8. Bayat S, Albu G, Layachi S, Portier F, Fathi M, Petak F, Habre W. Acute
hemorrhagic shock decreases airway resistance in anesthetized rat.
J Appl Physiol. 2011;111(2):458–64.
9. Petak F, Hantos Z, Adamicza A, Asztalos T, Sly PD. Methacholine-induced
bronchoconstriction in rats: effects of intravenous vs. aerosol delivery.
J Appl Physiol. 1997;82(5):1479–87.
10. Petak F, Banfi A, Toth-Szuki V, Barati L, Bari F, Szekely E, Novak Z. Airway
responsiveness and bronchoalveolar lavage fluid profiling in individual rats:
effects of different ovalbumin exposures. Respir Physiol Neurobiol.
2010;170(1):76–82.
11. Franken H, Clement J, Cauberghs M, Van de Woestijne KP. Oscillating flow
of a viscous compressible fluid through a rigid tube: a theoretical model.
IEEE Trans Biomed Eng. 1981;28(5):416–20.
12. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ. Input impedance and
peripheral inhomogeneity of dog lungs. J Appl Physiol. 1992;72(1):168–78.
13. Petak F, Hall GL, Sly PD. Repeated measurements of airway and
parenchymal mechanics in rats by using low-frequency oscillations. J Appl
Physiol. 1998;84(5):1680–6.
14. Lee HB, Blaufox MD. Blood volume in the rat. J Nucl Med. 1985;26(1):72–6.
15. Bain BJ, Bates I. Basic haematological techniques. In: Bain BJ, Lewis SM,
Bates I, editors. Practical Haematology. Edinburgh: Churchill Livingstone;
2001. p. 19–46.
16. Camilo LM, Avila MB, Cruz LF, Ribeiro GC, Spieth PM, Reske AA, Amato M,
Giannella-Neto A, Zin WA, Carvalho AR. Positive end-expiratory pressure and
variable ventilation in lung-healthy rats under general anesthesia. PLoS One.
2014;9(11):e110817.
17. Kudoh I, Segawa Y, Numata K, Kitamura H. PaO2 change during progressive
pulmonary edema in dogs. Crit Care Med. 1985;13(12):1020–4.
18. Perlman CE, Lederer DJ, Bhattacharya J. Micromechanics of alveolar edema.
Am J Respir Cell Mol Biol. 2011;44(1):34–9.
19. Robinson BRH, Cohen MJ, Holcomb JB, Pritts TA, Gomaa D, Fox EE, Branson
RD, Callcut RA, Cotton BA, Schreiber MA et al: Risk factors for the
development of acute respiratory distress syndrome following hemorrhage.
Shock. 2017. https://www.ncbi.nlm.nih.gov/pubmed/29194339.
20. Robinson BR, Cotton BA, Pritts TA, Branson R, Holcomb JB, Muskat P, Fox EE,
Wade CE, del Junco DJ, Bulger EM, et al. Application of the Berlin definition
in PROMMTT patients: the impact of resuscitation on the incidence of
hypoxemia. J Trauma Acute Care Surg. 2013;75(1 Suppl 1):S61–7.
21. Petak F, Fodor GH, Babik B, Habre W. Airway mechanics and lung tissue
viscoelasticity: effects of altered blood hematocrit in the pulmonary
circulation. J Appl Physiol. 2016;121(1):261–7.
22. Allen SJ. Fluid therapy and outcome: balance is best. J Extra Corpor
Technol. 2014;46(1):28–32.
23. Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid
therapies: effects on kidney function. Cochrane Database Syst Rev.
2013;7:CD007594.
24. Skhirtladze K, Base EM, Lassnigg A, Kaider A, Linke S, Dworschak M,
Hiesmayr MJ. Comparison of the effects of albumin 5%, hydroxyethyl starch
130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac
surgery. Br J Anaesth. 2014;112(2):255–64.
25. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, Investigators
SS. A comparison of albumin and saline for fluid resuscitation in the
intensive care unit. N Engl J Med. 2004;350(22):2247–56.
26. Lira A, Pinsky MR. Choices in fluid type and volume during resuscitation:
impact on patient outcomes. Ann Intensive Care. 2014;4:38.
27. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med. 2013;369(13):
1243–51.
28. Orbegozo Cortes D, Gamarano Barros T, Njimi H, Vincent JL. Crystalloids
versus colloids: exploring differences in fluid requirements by systematic
review and meta-regression. Anesth Analg. 2015;120(2):389–402.
29. Boland MR, Noorani A, Varty K, Coffey JC, Agha R, Walsh SR. Perioperative
fluid restriction in major abdominal surgery: systematic review and meta-
analysis of randomized, clinical trials. World J Surg. 2013;37(6):1193–202.
30. Aga Z, Machina M, McCluskey SA. Greater intravenous fluid volumes are
associated with prolonged recovery after colorectal surgery: a retrospective
cohort study. Br J Anaesth. 2016;116(6):804–10.
31. Brandstrup B, Tonnesen H, Beier-Holgersen R, Hjortso E, Ording H, Lindorff-
Larsen K, Rasmussen MS, Lanng C, Wallin L, Iversen LH, et al. Effects of
intravenous fluid restriction on postoperative complications: comparison of
two perioperative fluid regimens: a randomized assessor-blinded
multicenter trial. Ann Surg. 2003;238(5):641–8.
32. Navarro LH, Bloomstone JA, Auler JO Jr, Cannesson M, Rocca GD, Gan TJ,
Kinsky M, Magder S, Miller TE, Mythen M, et al. Perioperative fluid therapy: a
statement from the international fluid optimization group. Perioper Med
(Lond). 2015;4:3.
33. Della Rocca G, Vetrugno L, Tripi G, Deana C, Barbariol F, Pompei L. Liberal or
restricted fluid administration: are we ready for a proposal of a restricted
intraoperative approach? BMC Anesthesiol. 2014;14:62.
34. Smorenberg A, Ince C, Groeneveld AJ. Dose and type of crystalloid fluid
therapy in adult hospitalized patients. Perioper Med (Lond). 2013;2(1):17.
35. Burdett E, Dushianthan A, Bennett-Guerrero E, Cro S, Gan TJ, Grocott MP,
James MF, Mythen MG, O'Malley CM, Roche AM, et al. Perioperative
buffered versus non-buffered fluid administration for surgery in adults.
Cochrane Database Syst Rev. 2012;12:CD004089.
36. Phillips CR, Vinecore K, Hagg DS, Sawai RS, Differding JA, Watters JM,
Schreiber MA. Resuscitation of haemorrhagic shock with normal saline vs.
lactated Ringer's: effects on oxygenation, extravascular lung water and
haemodynamics. Crit Care. 2009;13(2):R30.
37. Barnas GM, Stamenovic D, Lutchen KR. Lung and chest wall impedances in
the dog in normal range of breathing: effects of pulmonary edema.
J Appl Physiol. 1992;73(3):1040–6.
Fodor et al. BMC Anesthesiology           (2019) 19:21 Page 9 of 9
